nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—Trandolapril—coronary artery disease	0.135	0.282	CrCtD
Aspartame—Enalapril—coronary artery disease	0.135	0.282	CrCtD
Aspartame—Lisinopril—coronary artery disease	0.105	0.221	CrCtD
Aspartame—Ramipril—coronary artery disease	0.102	0.214	CrCtD
Aspartame—SLC22A11—Pravastatin—coronary artery disease	0.0281	0.159	CbGbCtD
Aspartame—SLC22A11—Furosemide—coronary artery disease	0.0239	0.136	CbGbCtD
Aspartame—Enalapril—Captopril—coronary artery disease	0.0232	0.0733	CrCrCtD
Aspartame—SLC22A8—Enalapril—coronary artery disease	0.0231	0.131	CbGbCtD
Aspartame—SLC22A8—Pravastatin—coronary artery disease	0.0164	0.0928	CbGbCtD
Aspartame—SLC22A6—Enalapril—coronary artery disease	0.0161	0.0913	CbGbCtD
Aspartame—SLC22A8—Furosemide—coronary artery disease	0.0139	0.0789	CbGbCtD
Aspartame—Spirapril—Perindopril—coronary artery disease	0.0133	0.0422	CrCrCtD
Aspartame—Enalapril—Perindopril—coronary artery disease	0.0125	0.0396	CrCrCtD
Aspartame—Trandolapril—Perindopril—coronary artery disease	0.0125	0.0396	CrCrCtD
Aspartame—Ramipril—Perindopril—coronary artery disease	0.0125	0.0396	CrCrCtD
Aspartame—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0122	0.0692	CbGbCtD
Aspartame—Mitiglinide—Trandolapril—coronary artery disease	0.0121	0.0381	CrCrCtD
Aspartame—SLC22A6—Captopril—coronary artery disease	0.0121	0.0684	CbGbCtD
Aspartame—SLC22A6—Pravastatin—coronary artery disease	0.0114	0.0646	CbGbCtD
Aspartame—Quinapril—Perindopril—coronary artery disease	0.0106	0.0335	CrCrCtD
Aspartame—Lisinopril—Trandolapril—coronary artery disease	0.0104	0.033	CrCrCtD
Aspartame—Lisinopril—Enalapril—coronary artery disease	0.0104	0.033	CrCrCtD
Aspartame—Spirapril—Enalapril—coronary artery disease	0.0104	0.033	CrCrCtD
Aspartame—Spirapril—Trandolapril—coronary artery disease	0.0104	0.033	CrCrCtD
Aspartame—Ramipril—Enalapril—coronary artery disease	0.00977	0.0309	CrCrCtD
Aspartame—Trandolapril—Enalapril—coronary artery disease	0.00977	0.0309	CrCrCtD
Aspartame—Ramipril—Trandolapril—coronary artery disease	0.00977	0.0309	CrCrCtD
Aspartame—Enalapril—Trandolapril—coronary artery disease	0.00977	0.0309	CrCrCtD
Aspartame—SLC22A6—Furosemide—coronary artery disease	0.00968	0.0549	CbGbCtD
Aspartame—SLC22A6—Losartan—coronary artery disease	0.00949	0.0538	CbGbCtD
Aspartame—Mitiglinide—Ramipril—coronary artery disease	0.00913	0.0289	CrCrCtD
Aspartame—Nateglinide—Trandolapril—coronary artery disease	0.00871	0.0276	CrCrCtD
Aspartame—Nateglinide—Enalapril—coronary artery disease	0.00871	0.0276	CrCrCtD
Aspartame—Quinapril—Trandolapril—coronary artery disease	0.00828	0.0262	CrCrCtD
Aspartame—Quinapril—Enalapril—coronary artery disease	0.00828	0.0262	CrCrCtD
Aspartame—Spirapril—Lisinopril—coronary artery disease	0.00815	0.0258	CrCrCtD
Aspartame—Lisinopril—Ramipril—coronary artery disease	0.00789	0.025	CrCrCtD
Aspartame—Spirapril—Ramipril—coronary artery disease	0.00789	0.025	CrCrCtD
Aspartame—Enalapril—Lisinopril—coronary artery disease	0.00765	0.0242	CrCrCtD
Aspartame—Trandolapril—Lisinopril—coronary artery disease	0.00765	0.0242	CrCrCtD
Aspartame—Ramipril—Lisinopril—coronary artery disease	0.00765	0.0242	CrCrCtD
Aspartame—Lisdexamfetamine—Lisinopril—coronary artery disease	0.00765	0.0242	CrCrCtD
Aspartame—Trandolapril—Ramipril—coronary artery disease	0.00741	0.0234	CrCrCtD
Aspartame—Enalapril—Ramipril—coronary artery disease	0.00741	0.0234	CrCrCtD
Aspartame—Nateglinide—Lisinopril—coronary artery disease	0.00682	0.0216	CrCrCtD
Aspartame—Nateglinide—Ramipril—coronary artery disease	0.0066	0.0209	CrCrCtD
Aspartame—Quinapril—Lisinopril—coronary artery disease	0.00648	0.0205	CrCrCtD
Aspartame—Quinapril—Ramipril—coronary artery disease	0.00627	0.0198	CrCrCtD
Aspartame—TRPV1—vagus nerve—coronary artery disease	0.00136	0.962	CbGeAlD
Aspartame—Bortezomib—PSMB5—coronary artery disease	0.000638	0.324	CrCbGaD
Aspartame—Lisinopril—ACE2—coronary artery disease	0.000375	0.191	CrCbGaD
Aspartame—Lacosamide—CA5B—coronary artery disease	0.000158	0.0803	CrCbGaD
Aspartame—Spirapril—ACE—coronary artery disease	8.89e-05	0.0453	CrCbGaD
Aspartame—Mitiglinide—PPARG—coronary artery disease	8.5e-05	0.0432	CrCbGaD
Aspartame—Quinapril—ACE—coronary artery disease	7.93e-05	0.0403	CrCbGaD
Aspartame—Lisinopril—ACE—coronary artery disease	7.93e-05	0.0403	CrCbGaD
Aspartame—Ramipril—ACE—coronary artery disease	7.68e-05	0.0391	CrCbGaD
Aspartame—Trandolapril—ACE—coronary artery disease	7.68e-05	0.0391	CrCbGaD
Aspartame—Amphetamine—SLC22A3—coronary artery disease	6.93e-05	0.0352	CrCbGaD
Aspartame—Methamphetamine—SLC22A3—coronary artery disease	6.42e-05	0.0327	CrCbGaD
Aspartame—Enalapril—ACE—coronary artery disease	5.82e-05	0.0296	CrCbGaD
Aspartame—Bortezomib—CYP2C19—coronary artery disease	5.71e-05	0.0291	CrCbGaD
Aspartame—SLC22A8—blood—coronary artery disease	5.41e-05	0.0383	CbGeAlD
Aspartame—SLC22A11—Transmembrane transport of small molecules—FXYD1—coronary artery disease	5.35e-05	0.00195	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—HK1—coronary artery disease	5.33e-05	0.00194	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	5.33e-05	0.00194	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PPBP—coronary artery disease	5.27e-05	0.00192	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PGF—coronary artery disease	5.27e-05	0.00192	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDNRA—coronary artery disease	5.25e-05	0.00192	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADRB1—coronary artery disease	5.23e-05	0.00191	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DVL1—coronary artery disease	5.18e-05	0.00189	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITGA2B—coronary artery disease	5.18e-05	0.00189	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—HK2—coronary artery disease	5.18e-05	0.00189	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—POMC—coronary artery disease	5.16e-05	0.00188	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CCL2—coronary artery disease	5.05e-05	0.00184	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL4—coronary artery disease	5.02e-05	0.00183	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GHR—coronary artery disease	5.02e-05	0.00183	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—OPRD1—coronary artery disease	5.02e-05	0.00183	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	4.96e-05	0.00181	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—BDKRB2—coronary artery disease	4.94e-05	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL12—coronary artery disease	4.94e-05	0.0018	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PLCB1—coronary artery disease	4.83e-05	0.00176	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MEF2A—coronary artery disease	4.82e-05	0.00176	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TLE4—coronary artery disease	4.82e-05	0.00176	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	4.77e-05	0.00174	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CFTR—coronary artery disease	4.77e-05	0.00174	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HTR7—coronary artery disease	4.73e-05	0.00172	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOA2—coronary artery disease	4.69e-05	0.00171	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AVPR1A—coronary artery disease	4.64e-05	0.00169	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	4.55e-05	0.00166	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KNG1—coronary artery disease	4.49e-05	0.00164	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—UTS2—coronary artery disease	4.48e-05	0.00163	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGTR1—coronary artery disease	4.47e-05	0.00163	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	4.44e-05	0.00162	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	4.4e-05	0.00161	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NR4A1—coronary artery disease	4.38e-05	0.0016	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL10—coronary artery disease	4.37e-05	0.00159	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—P2RY12—coronary artery disease	4.34e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLCB3—coronary artery disease	4.34e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HDAC9—coronary artery disease	4.34e-05	0.00158	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	4.33e-05	0.00158	CbGpPWpGaD
Aspartame—Nateglinide—PPARG—coronary artery disease	4.33e-05	0.022	CrCbGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—HK2—coronary artery disease	4.32e-05	0.00158	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CX3CR1—coronary artery disease	4.29e-05	0.00157	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASR—coronary artery disease	4.29e-05	0.00157	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—CETP—coronary artery disease	4.28e-05	0.00156	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—ADRB2—coronary artery disease	4.24e-05	0.00155	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BDKRB1—coronary artery disease	4.21e-05	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CX3CL1—coronary artery disease	4.21e-05	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—P4HB—coronary artery disease	4.21e-05	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GNA12—coronary artery disease	4.21e-05	0.00154	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCE—coronary artery disease	4.18e-05	0.00153	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	4.14e-05	0.00151	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PPP3R1—coronary artery disease	4.13e-05	0.00151	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADM—coronary artery disease	4.1e-05	0.00149	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—FXYD1—coronary artery disease	4.08e-05	0.00149	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—HK1—coronary artery disease	4.06e-05	0.00148	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	4.06e-05	0.00148	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TFRC—coronary artery disease	4.06e-05	0.00148	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDE4B—coronary artery disease	3.99e-05	0.00146	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CYBB—coronary artery disease	3.99e-05	0.00146	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	3.99e-05	0.00145	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCL8—coronary artery disease	3.99e-05	0.00145	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MMP3—coronary artery disease	3.98e-05	0.00145	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RYR2—coronary artery disease	3.81e-05	0.00139	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—COX5B—coronary artery disease	3.81e-05	0.00139	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EDN1—coronary artery disease	3.79e-05	0.00138	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLAT—coronary artery disease	3.77e-05	0.00138	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL5—coronary artery disease	3.76e-05	0.00137	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLN—coronary artery disease	3.71e-05	0.00135	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CSF2—coronary artery disease	3.7e-05	0.00135	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	3.67e-05	0.00134	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCR3—coronary artery disease	3.65e-05	0.00133	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	3.64e-05	0.00133	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CFTR—coronary artery disease	3.64e-05	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CRK—coronary artery disease	3.6e-05	0.00131	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VWF—coronary artery disease	3.56e-05	0.0013	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ATP2A2—coronary artery disease	3.56e-05	0.0013	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SH2B3—coronary artery disease	3.56e-05	0.0013	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOC3—coronary artery disease	3.54e-05	0.00129	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LDLR—coronary artery disease	3.51e-05	0.00128	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	3.47e-05	0.00127	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HK2—coronary artery disease	3.45e-05	0.00126	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PPP2CA—coronary artery disease	3.45e-05	0.00126	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL3—coronary artery disease	3.43e-05	0.00125	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL2—coronary artery disease	3.43e-05	0.00125	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—FXYD1—coronary artery disease	3.41e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SDC1—coronary artery disease	3.39e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—F2R—coronary artery disease	3.39e-05	0.00124	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	3.39e-05	0.00124	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—HK1—coronary artery disease	3.39e-05	0.00124	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PRKCD—coronary artery disease	3.39e-05	0.00123	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGB—coronary artery disease	3.32e-05	0.00121	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—HTR2A—coronary artery disease	3.31e-05	0.00121	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—C3—coronary artery disease	3.31e-05	0.00121	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP4A—coronary artery disease	3.31e-05	0.00121	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	3.31e-05	0.00121	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRB—coronary artery disease	3.29e-05	0.0012	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—THBS1—coronary artery disease	3.24e-05	0.00118	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—PLG—coronary artery disease	3.21e-05	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSMA6—coronary artery disease	3.21e-05	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PSMB5—coronary artery disease	3.21e-05	0.00117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AGT—coronary artery disease	3.14e-05	0.00115	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDNRA—coronary artery disease	3.1e-05	0.00113	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB1—coronary artery disease	3.09e-05	0.00113	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CYBA—coronary artery disease	3.09e-05	0.00113	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DUSP6—coronary artery disease	3.08e-05	0.00112	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	3.04e-05	0.00111	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CFTR—coronary artery disease	3.04e-05	0.00111	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	3.04e-05	0.00111	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLAT—coronary artery disease	3.02e-05	0.0011	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	2.96e-05	0.00108	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	2.93e-05	0.00107	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	2.93e-05	0.00107	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BDKRB2—coronary artery disease	2.92e-05	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL12—coronary artery disease	2.92e-05	0.00106	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RYR2—coronary artery disease	2.91e-05	0.00106	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—COX5B—coronary artery disease	2.91e-05	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—F2—coronary artery disease	2.9e-05	0.00106	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	2.9e-05	0.00106	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6ST—coronary artery disease	2.89e-05	0.00105	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JUNB—coronary artery disease	2.86e-05	0.00104	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLCB1—coronary artery disease	2.85e-05	0.00104	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOB—coronary artery disease	2.84e-05	0.00103	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLN—coronary artery disease	2.83e-05	0.00103	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HTR7—coronary artery disease	2.79e-05	0.00102	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ABCG5—coronary artery disease	2.71e-05	0.000987	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HK1—coronary artery disease	2.71e-05	0.000987	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	2.71e-05	0.000987	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITGAV—coronary artery disease	2.66e-05	0.000971	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KNG1—coronary artery disease	2.66e-05	0.000968	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—POMC—coronary artery disease	2.65e-05	0.000965	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CREB1—coronary artery disease	2.65e-05	0.000965	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGTR1—coronary artery disease	2.64e-05	0.000962	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HK2—coronary artery disease	2.63e-05	0.000959	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCL2—coronary artery disease	2.59e-05	0.000944	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6R—coronary artery disease	2.58e-05	0.000941	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL10—coronary artery disease	2.58e-05	0.00094	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PLG—coronary artery disease	2.57e-05	0.000938	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	2.54e-05	0.000926	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	2.52e-05	0.00092	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP4A—coronary artery disease	2.52e-05	0.00092	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ADRB2—coronary artery disease	2.5e-05	0.000913	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCE—coronary artery disease	2.47e-05	0.000901	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SOCS1—coronary artery disease	2.47e-05	0.000899	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—S100B—coronary artery disease	2.46e-05	0.000897	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SOCS3—coronary artery disease	2.44e-05	0.000888	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—COX5B—coronary artery disease	2.43e-05	0.000885	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RYR2—coronary artery disease	2.43e-05	0.000885	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFBR2—coronary artery disease	2.41e-05	0.000878	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KITLG—coronary artery disease	2.41e-05	0.000878	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLN—coronary artery disease	2.36e-05	0.000861	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP3—coronary artery disease	2.35e-05	0.000858	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT5A—coronary artery disease	2.35e-05	0.000858	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOB—coronary artery disease	2.27e-05	0.000829	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.24e-05	0.000818	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—JAK2—coronary artery disease	2.24e-05	0.000818	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EDN1—coronary artery disease	2.24e-05	0.000816	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	2.24e-05	0.000816	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	2.24e-05	0.000816	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL5—coronary artery disease	2.22e-05	0.00081	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HK2—coronary artery disease	2.2e-05	0.000801	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF1—coronary artery disease	2.19e-05	0.000797	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CSF2—coronary artery disease	2.19e-05	0.000797	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LPL—coronary artery disease	2.17e-05	0.000792	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RPS6KB1—coronary artery disease	2.15e-05	0.000784	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MEF2C—coronary artery disease	2.15e-05	0.000784	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	2.11e-05	0.000768	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP4A—coronary artery disease	2.11e-05	0.000768	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ITGB3—coronary artery disease	2.1e-05	0.000764	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	2.08e-05	0.000757	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ABCG5—coronary artery disease	2.06e-05	0.000753	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HK1—coronary artery disease	2.06e-05	0.000753	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	2.06e-05	0.000753	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL8—coronary artery disease	2.05e-05	0.000746	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PPP2CA—coronary artery disease	2.04e-05	0.000743	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	2.03e-05	0.000739	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—CETP—coronary artery disease	2e-05	0.000731	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PRKCD—coronary artery disease	2e-05	0.000729	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HTR2A—coronary artery disease	1.96e-05	0.000714	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—C3—coronary artery disease	1.95e-05	0.000713	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.9e-05	0.000693	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.87e-05	0.000681	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.87e-05	0.000681	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—coronary artery disease	1.86e-05	0.00068	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AGT—coronary artery disease	1.86e-05	0.000677	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOE—coronary artery disease	1.82e-05	0.000664	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LEP—coronary artery disease	1.82e-05	0.000664	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APOA1—coronary artery disease	1.8e-05	0.000656	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KDR—coronary artery disease	1.78e-05	0.00065	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.78e-05	0.000648	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK14—coronary artery disease	1.77e-05	0.000646	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.77e-05	0.000644	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ESR1—coronary artery disease	1.74e-05	0.000633	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.72e-05	0.000628	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.72e-05	0.000628	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HK1—coronary artery disease	1.72e-05	0.000628	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—F2—coronary artery disease	1.72e-05	0.000626	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FN1—coronary artery disease	1.72e-05	0.000626	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6ST—coronary artery disease	1.71e-05	0.000623	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NFKBIA—coronary artery disease	1.7e-05	0.000618	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KIT—coronary artery disease	1.64e-05	0.000599	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—ALB—coronary artery disease	1.64e-05	0.000597	CbGpPWpGaD
Aspartame—Nateglinide—ALB—coronary artery disease	1.63e-05	0.00828	CrCbGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.58e-05	0.000578	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GSK3B—coronary artery disease	1.58e-05	0.000575	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—POMC—coronary artery disease	1.56e-05	0.00057	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CREB1—coronary artery disease	1.56e-05	0.00057	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.55e-05	0.000564	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCL2—coronary artery disease	1.53e-05	0.000558	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—CETP—coronary artery disease	1.53e-05	0.000557	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6R—coronary artery disease	1.52e-05	0.000556	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IGF1—coronary artery disease	1.5e-05	0.000548	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—PLG—coronary artery disease	1.5e-05	0.000548	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MAPK1—coronary artery disease	1.5e-05	0.000546	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.45e-05	0.000528	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SERPINE1—coronary artery disease	1.43e-05	0.000521	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.39e-05	0.000505	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF2—coronary artery disease	1.38e-05	0.000504	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOS3—coronary artery disease	1.36e-05	0.000497	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.35e-05	0.000491	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOB—coronary artery disease	1.33e-05	0.000484	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAK2—coronary artery disease	1.32e-05	0.000483	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.32e-05	0.000482	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CA—coronary artery disease	1.3e-05	0.000473	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.29e-05	0.00047	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—CETP—coronary artery disease	1.28e-05	0.000465	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—ALB—coronary artery disease	1.25e-05	0.000455	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL8—coronary artery disease	1.21e-05	0.000441	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.21e-05	0.000441	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—coronary artery disease	1.16e-05	0.000422	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL6—coronary artery disease	1.15e-05	0.000419	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—PLG—coronary artery disease	1.15e-05	0.000418	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCND1—coronary artery disease	1.13e-05	0.000411	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.12e-05	0.00041	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—coronary artery disease	1.09e-05	0.000399	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—coronary artery disease	1.06e-05	0.000387	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.06e-05	0.000385	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.05e-05	0.000383	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—ALB—coronary artery disease	1.04e-05	0.00038	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOB—coronary artery disease	1.01e-05	0.000369	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—coronary artery disease	9.82e-06	0.000358	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—PLG—coronary artery disease	9.56e-06	0.000349	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TGFB1—coronary artery disease	9.01e-06	0.000329	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MAPK1—coronary artery disease	8.84e-06	0.000322	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—HMOX1—coronary artery disease	8.82e-06	0.000322	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOB—coronary artery disease	8.45e-06	0.000308	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ALB—coronary artery disease	8.32e-06	0.000303	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.01e-06	0.000292	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CA—coronary artery disease	7.67e-06	0.00028	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL6—coronary artery disease	6.79e-06	0.000248	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.68e-06	0.000244	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ALB—coronary artery disease	6.35e-06	0.000231	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—coronary artery disease	6.27e-06	0.000228	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	5.3e-06	0.000193	CbGpPWpGaD
